502.550.07002 Boehringer Ingelheim Investigational Site

Moscow

0 studies enrolling now · 1 studies all time

What they study most

Hypertension

Studies at this site

• Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension — Completed